SCHEMBL18558987

SCHEMBL18558987

CC(C)c1nnc(C(C)CCC(C)c2nnc(C(C)C)c3nccnc23)c2ncccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.37
L3MBTL1 Q9Y468 4/20 0.37
HSP90AA1 P07900 1/20 0.37
IDO1 P14902 2/20 0.33
GRM4 Q14833 1/20 0.33
HTT P42858 4/20 0.33
KDM4E B2RXH2 3/20 0.33
RAB9A P51151 3/20 0.33
MAPT P10636 3/20 0.33
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
CCR1 P32246 1/20 0.32
CCR8 P51685 1/20 0.32
PSMD14 O00487 1/20 0.32
COPS5 Q92905 1/20 0.32
SLC6A2 P23975 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18559161 0.88 L3MBTL1 (0.42) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL17705704 0.87 HSP90AA1 (0.47) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL26433550 0.74 KDM4E (0.42) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL17705706 0.74 CCNB2 (0.31)
SCHEMBL26866930 0.68 L3MBTL1 (0.45) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL18558989 0.68 GPR84 (0.35) NPC1IDO1HTTKDM4ERAB9A
SCHEMBL13171259 0.67 L3MBTL1 (0.44) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL22035506 0.66 HSP90AA1 (0.42) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL19860969 0.66 CCR1 (0.47) NPC1L3MBTL1HSP90AA1IDO1HTT
SCHEMBL14431324 0.66 GPR84 (0.41) KDM4EMAPTCYP2C19SLC6A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9579319-B2 Heterocyclic compounds as hedgehog signaling pathway inhibitors REDX PHARMA PLC (GB) 2017-02-28 US disclosed